Abstract PD2-16: Risk of breast cancer after a false-positive screening mammogram in relation to mammographic abnormality: A population-based study in British Columbia

Background Breast cancer screening by mammography has been shown to reduce breast cancer mortality, however false positive recall rates have consistently been identified as a harm of organized screening. The extent to which these recalled women are at increased risk of future breast cancer remains unclear. Methods The British Columbia Cancer Agency Screening Mammography Program (SMP), the first organized breast screening program in Canada offers screening mammography for women aged 40-74 since 1988. All women who had two or more screening mammograms between1988-2013 within the SMP were included in the study. They were followed until a breast cancer diagnosis, last screen date +5 years, or end of follow-up on Dec 31, 2013, whichever came first. The relative risk (RR) of breast cancer for women with a false-positive test compared with women with negative tests was estimated with Poisson regression, adjusted for age, and five calendar periods. Results A total of 772,289 women with 4.82 million screening mammograms and a median follow up of 11.8 years were included. There were 238,860 women with false positive findings and 26,950 cancers of which 16,084 screen detected and 10,866 non screen detected. Women without any false positive mammogram had a cancer incidence rate of 245/100 000 person-years at risk, whereas women with a false-positive test had an absolute rate of 447/100 000 person-years at risk. The adjusted RR [Value (95% CI)] of breast cancer after the first false-positive test was 1.73(1.68-1.77) for all, 1.65(1.61-1.70) for invasive, and 2.13(2.01-2.27) for in situ cancers respectively. The RR remained increased beyond 8 years after the false-positive test. Of the 5157 screen detected cancers after the first false positive test, 3358 (65%) were on the ipsilateral breast while 1799 (35%) were on the contralateral breast. Women with only one, two, three or four+ false positive test(s) had RR of 1.88(1.83-1.93), 1.42(1.35-1.49), 1.17(1.05-1.30), and 1.08(0.87-1.34) respectively for all cancers. Women with breast density >50% at the time of false positive test had a twofold risk of breast cancer with a RR of 2.07(1.99-2.14), while those with breast density Conclusion False positive mammogram correlates with an increased risk of developing breast cancer. 65% of the screen detected breast cancers post false positive mammogram occur in the ipsilateral breast. Mammographic abnormality features of the false positive mammogram are found to be predictors for the type of future breast cancer. Mammographic features at the time of recall predicts risk of subsequent cancer and may warrant increased surveillance. Citation Format: Rajapakshe R, Miao H, Sam J, Farnquist B, Hartman M. Risk of breast cancer after a false-positive screening mammogram in relation to mammographic abnormality: A population-based study in British Columbia [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr PD2-16.